FDA issues warning on Medtronic insulin pump vulnerabilities

The Federal Drug Administration (FDA) warned patients and healthcare providers vulnerabilities that impact certain Medtronic insulin pumps. Medtronic confirmed the risks and issued recalls to replace MiniMed™ 508 insulin pump and the MiniMed™ Paradigm™ series insulin pump models.

Continue Reading FDA issues warning on Medtronic insulin pump vulnerabilities